vs

Side-by-side financial comparison of CANTALOUPE, INC. (CTLP) and DYNAVAX TECHNOLOGIES CORP (DVAX). Click either name above to swap in a different company.

DYNAVAX TECHNOLOGIES CORP is the larger business by last-quarter revenue ($94.9M vs $78.7M, roughly 1.2× CANTALOUPE, INC.). DYNAVAX TECHNOLOGIES CORP runs the higher net margin — 28.4% vs -0.1%, a 28.5% gap on every dollar of revenue. On growth, DYNAVAX TECHNOLOGIES CORP posted the faster year-over-year revenue change (17.7% vs 6.8%). DYNAVAX TECHNOLOGIES CORP produced more free cash flow last quarter ($32.6M vs $-614.0K). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs 7.7%).

Cantaloupe, Inc., previously known as USA Technologies Inc., is an American company known for its work with ePort cashless acceptance technology running on its patented ePort Connect service, a PCI compliant services. ePort Connect wirelessly facilitates electronic payment options to consumers with credit, debit, or NFC enabled electronic wallets like Apple Pay and Google Pay while providing operators with both telemetry and machine-to-machine (M2M) services. ePort technology is primarily fou...

Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.

CTLP vs DVAX — Head-to-Head

Bigger by revenue
DVAX
DVAX
1.2× larger
DVAX
$94.9M
$78.7M
CTLP
Growing faster (revenue YoY)
DVAX
DVAX
+10.9% gap
DVAX
17.7%
6.8%
CTLP
Higher net margin
DVAX
DVAX
28.5% more per $
DVAX
28.4%
-0.1%
CTLP
More free cash flow
DVAX
DVAX
$33.2M more FCF
DVAX
$32.6M
$-614.0K
CTLP
Faster 2-yr revenue CAGR
DVAX
DVAX
Annualised
DVAX
30.6%
7.7%
CTLP

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
CTLP
CTLP
DVAX
DVAX
Revenue
$78.7M
$94.9M
Net Profit
$-70.0K
$26.9M
Gross Margin
Operating Margin
2.0%
22.4%
Net Margin
-0.1%
28.4%
Revenue YoY
6.8%
17.7%
Net Profit YoY
-101.4%
53.0%
EPS (diluted)
$0.00
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTLP
CTLP
DVAX
DVAX
Q4 25
$78.7M
Q3 25
$80.9M
$94.9M
Q2 25
$82.6M
$95.4M
Q1 25
$75.4M
$68.2M
Q4 24
$73.7M
$72.0M
Q3 24
$70.8M
$80.6M
Q2 24
$72.7M
$73.8M
Q1 24
$67.9M
$50.8M
Net Profit
CTLP
CTLP
DVAX
DVAX
Q4 25
$-70.0K
Q3 25
$-919.0K
$26.9M
Q2 25
$6.8M
$18.7M
Q1 25
$49.2M
$-96.1M
Q4 24
$5.0M
$7.0M
Q3 24
$3.6M
$17.6M
Q2 24
$2.2M
$11.4M
Q1 24
$4.7M
$-8.7M
Gross Margin
CTLP
CTLP
DVAX
DVAX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
39.6%
Operating Margin
CTLP
CTLP
DVAX
DVAX
Q4 25
2.0%
Q3 25
2.0%
22.4%
Q2 25
6.3%
15.1%
Q1 25
9.1%
-34.7%
Q4 24
8.4%
-2.3%
Q3 24
5.8%
12.5%
Q2 24
4.9%
7.0%
Q1 24
6.3%
-35.0%
Net Margin
CTLP
CTLP
DVAX
DVAX
Q4 25
-0.1%
Q3 25
-1.1%
28.4%
Q2 25
8.3%
19.6%
Q1 25
65.2%
-141.0%
Q4 24
6.7%
9.8%
Q3 24
5.0%
21.8%
Q2 24
3.0%
15.4%
Q1 24
6.9%
-17.2%
EPS (diluted)
CTLP
CTLP
DVAX
DVAX
Q4 25
$0.00
Q3 25
$-0.02
$0.21
Q2 25
$0.10
$0.14
Q1 25
$0.65
$-0.77
Q4 24
$0.07
$0.07
Q3 24
$0.04
$0.12
Q2 24
$0.03
$0.08
Q1 24
$0.06
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTLP
CTLP
DVAX
DVAX
Cash + ST InvestmentsLiquidity on hand
$53.0M
$160.2M
Total DebtLower is stronger
$37.7M
Stockholders' EquityBook value
$252.5M
$534.1M
Total Assets
$381.9M
$946.5M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTLP
CTLP
DVAX
DVAX
Q4 25
$53.0M
Q3 25
$55.0M
$160.2M
Q2 25
$51.1M
$99.1M
Q1 25
$46.3M
$51.7M
Q4 24
$27.7M
$95.9M
Q3 24
$33.1M
$119.3M
Q2 24
$58.9M
$112.5M
Q1 24
$50.2M
$132.0M
Total Debt
CTLP
CTLP
DVAX
DVAX
Q4 25
$37.7M
Q3 25
$38.3M
Q2 25
$38.7M
Q1 25
$39.2M
Q4 24
$37.0M
Q3 24
$37.3M
Q2 24
$37.5M
Q1 24
$38.1M
Stockholders' Equity
CTLP
CTLP
DVAX
DVAX
Q4 25
$252.5M
Q3 25
$251.8M
$534.1M
Q2 25
$251.0M
$494.2M
Q1 25
$240.7M
$530.9M
Q4 24
$190.1M
$596.8M
Q3 24
$186.2M
$681.4M
Q2 24
$181.7M
$642.8M
Q1 24
$178.8M
$618.5M
Total Assets
CTLP
CTLP
DVAX
DVAX
Q4 25
$381.9M
Q3 25
$389.5M
$946.5M
Q2 25
$381.9M
$918.4M
Q1 25
$370.5M
$945.9M
Q4 24
$303.0M
$986.3M
Q3 24
$312.1M
$1.1B
Q2 24
$335.6M
$1.0B
Q1 24
$319.9M
$986.6M
Debt / Equity
CTLP
CTLP
DVAX
DVAX
Q4 25
0.15×
Q3 25
0.15×
Q2 25
0.15×
Q1 25
0.16×
Q4 24
0.19×
Q3 24
0.20×
Q2 24
0.21×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTLP
CTLP
DVAX
DVAX
Operating Cash FlowLast quarter
$3.1M
$33.8M
Free Cash FlowOCF − Capex
$-614.0K
$32.6M
FCF MarginFCF / Revenue
-0.8%
34.4%
Capex IntensityCapex / Revenue
4.8%
1.3%
Cash ConversionOCF / Net Profit
1.26×
TTM Free Cash FlowTrailing 4 quarters
$25.8M
$80.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTLP
CTLP
DVAX
DVAX
Q4 25
$3.1M
Q3 25
$7.0M
$33.8M
Q2 25
$9.4M
$23.4M
Q1 25
$22.4M
$-19.6M
Q4 24
$522.0K
$53.0M
Q3 24
$-12.0M
$19.5M
Q2 24
$14.3M
$10.7M
Q1 24
$14.7M
$-16.7M
Free Cash Flow
CTLP
CTLP
DVAX
DVAX
Q4 25
$-614.0K
Q3 25
$3.5M
$32.6M
Q2 25
$4.3M
$22.0M
Q1 25
$18.6M
$-23.6M
Q4 24
$-3.8M
$49.5M
Q3 24
$-15.8M
$18.1M
Q2 24
$8.5M
$9.9M
Q1 24
$11.4M
$-17.4M
FCF Margin
CTLP
CTLP
DVAX
DVAX
Q4 25
-0.8%
Q3 25
4.4%
34.4%
Q2 25
5.3%
23.0%
Q1 25
24.6%
-34.6%
Q4 24
-5.1%
68.8%
Q3 24
-22.3%
22.5%
Q2 24
11.7%
13.5%
Q1 24
16.9%
-34.3%
Capex Intensity
CTLP
CTLP
DVAX
DVAX
Q4 25
4.8%
Q3 25
4.2%
1.3%
Q2 25
6.2%
1.5%
Q1 25
5.1%
5.8%
Q4 24
5.8%
4.8%
Q3 24
5.4%
1.7%
Q2 24
7.9%
1.1%
Q1 24
4.8%
1.5%
Cash Conversion
CTLP
CTLP
DVAX
DVAX
Q4 25
Q3 25
1.26×
Q2 25
1.38×
1.25×
Q1 25
0.46×
Q4 24
0.10×
7.52×
Q3 24
-3.36×
1.11×
Q2 24
6.47×
0.94×
Q1 24
3.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTLP
CTLP

Transaction Processing$47.9M61%
Subscription Revenue$21.8M28%
Products$9.0M11%

DVAX
DVAX

HEPLISAVB$90.0M95%
US Department Of Defense$4.7M5%

Related Comparisons